Talita Souza Carmo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Talita Souza Carmo has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Milton Vieira Gomes
Grupo Engenharia de Biocatalisadores, Departamento de Biologia Celular, Instituto de Ciências Biológicas Bloco K 1º andar, Universidade de Brasília, Campus Darcy Ribeiro, CEP 70.790-900 Brasília-DF, Brazil
1 shared publication - Frederico Mendonça Bahia
School of Science, Jacobs University Bremen gGmbH, Campus Ring 1, 28759 Bremen, Germany
1 shared publication Gabriela Carneiro da Almeida
1 shared publicationJuliana Davies de Oliveira
1 shared publicationLucas Silva Carvalho
1 shared publication- Lucas Silva Carvalho
Grupo de Engenharia de Biocatalisadores, Departamento de Biologia Celular, Instituto de Ciências Biológicas, Universidade de Brasília (UnB), Campus Darcy Ribeiro, Bloco K. Brasilia, Federal District 70790-900, Brazil
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 29 April 2018
- Published by MDPI AG in Microorganisms
- Vol. 6 (2) , 38
Comparison of Yeasts as Hosts for Recombinant Protein Production
Recombinant protein production emerged in the early 1980s with the development of genetic engineering tools, which represented a compelling alternative to protein extraction from natural sources. Over the years, a high level of heterologous protein was made possible in a variety of hosts ranging from the bacteria Escherichia coli to mammalian cells. Recombinant protein importance is represented by its market size, which reached $1654 million in 2016 and is expected to reach $2850.5 million by 2022. Among the available hosts, yeasts have been used for producing a great variety of proteins applied to chemicals, fuels, food, and pharmaceuticals, being one of the most used hosts for recombinant production nowadays. Historically, Saccharomyces cerevisiae was the dominant yeast host for heterologous protein production. Lately, other yeasts such as Komagataella sp., Kluyveromyces lactis, and Yarrowia lipolytica have emerged as advantageous hosts. In this review, a comparative analysis is done listing the advantages and disadvantages of using each host regarding the availability of genetic tools, strategies for cultivation in bioreactors, and the main techniques utilized for protein purification. Finally, examples of each host will be discussed regarding the total amount of protein recovered and its bioactivity due to correct folding and glycosylation patterns.
- 29 April 2018
- Published by MDPI AG in Microorganisms
- Vol. 6 (2) , 38
Top Cited PapersOpen AccessComparison of Yeasts as Hosts for Recombinant Protein Production
Recombinant protein production emerged in the early 1980s with the development of genetic engineering tools, which represented a compelling alternative to protein extraction from natural sources. Over the years, a high level of heterologous protein was made possible in a variety of hosts ranging from the bacteria Escherichia coli to mammalian cells. Recombinant protein importance is represented by its market size, which reached $1654 million in 2016 and is expected to reach $2850.5 million by 2022. Among the available hosts, yeasts have been used for producing a great variety of proteins applied to chemicals, fuels, food, and pharmaceuticals, being one of the most used hosts for recombinant production nowadays. Historically, Saccharomyces cerevisiae was the dominant yeast host for heterologous protein production. Lately, other yeasts such as Komagataella sp., Kluyveromyces lactis, and Yarrowia lipolytica have emerged as advantageous hosts. In this review, a comparative analysis is done listing the advantages and disadvantages of using each host regarding the availability of genetic tools, strategies for cultivation in bioreactors, and the main techniques utilized for protein purification. Finally, examples of each host will be discussed regarding the total amount of protein recovered and its bioactivity due to correct folding and glycosylation patterns.
- Open Access
- 8 February 2017
- Published by IntechOpen
Production Processes for Monoclonal Antibodies
Production Processes for Monoclonal Antibodies | InTechOpen, Published on: 2017-02-08. Authors: Lucas Silva Carvalho, Otávio Bravim da Silva, Gabriela Carneiro de Almeida, et
- 8 February 2017
- Published by IntechOpen
Open AccessProduction Processes for Monoclonal Antibodies
Production Processes for Monoclonal Antibodies | InTechOpen, Published on: 2017-02-08. Authors: Lucas Silva Carvalho, Otávio Bravim da Silva, Gabriela Carneiro de Almeida, et